Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases

Postdoc J. 2014 Jun;2(6):1-11. doi: 10.14304/surya.jpr.v2n6.1.

Abstract

IL2-inducible T-cell kinase (ITK), a member of the Tec family tyrosine kinases, is the predominant Tec kinase in T cells and natural killer (NK) cells mediating T cell receptor (TCR) and Fc receptor (Fc R) initiated signal transduction. ITK deficiency results in impaired T and NK cell functions, leading to various disorders including malignancies, inflammation, and autoimmune diseases. In this mini-review, the role of ITK in T cell signaling and the development of small molecule inhibitors of ITK for the treatment of T-cell related disorders is examined.

Keywords: IL2-inducible T-cell kinase (ITK); T cell signaling; inhibitors of ITK.